BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Axsome Takes New Approach, Targets NMDA Receptors With AXS-05 to Treat Depression

  Axsome Therapeutics announced that it published the results of its Ascend Phase-II clinical trial of AXS-05 to treat Major Depressive Disorder in The American Journal of Psychiatry.

  May 18, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Drug Development

  Capsida, Adverum, Instil and Metagenomi Showcase Therapies at ASGCT (Updated)

  The American Society of Gene and Cell Therapy annual meeting continues to see companies showcasing promising therapeutics for multiple disease indications.

  May 18, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  Why Pfizer May Be Holding Paxlovid Close to the Chest

  Pfizer apparently hasn’t begun any combination trials in human beings of Paxlovid, and no reported human tests are using the drug in combination with other therapies.

  May 18, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  Warren Buffet’s Latest Moves Reflect Biopharma Market Woes

  Possibly reflecting the current Bear market, Berkshire Hathaway has walked away from its stake in both AbbVie and BMS.

  May 18, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Fighting Neurodegeneration by Targeting Fossil Viruses in DNA

  GeNeuro is developing therapeutics that tackle the viral proteins that potentially contribute to neurodegeneration seen in patients with MS, amyotrophic lateral sclerosis (ALS) and even COVID-19.

  May 18, 2022

   · 

  6 min read

   · 

  Hayley Shasteen
• 

  Business

  Virongy Biosciences Announces Expansion, Creation of up to 70 New Jobs

  Virongy is expanding again and has committed to a $471,000 expansion with up to 70 new jobs.

  May 18, 2022

   · 

  2 min read

   · 

  Hannah Chudleigh
• 

  Researchers May Have Unlocked Mechanism Driving Inflammation in Rheumatoid Arthritis

  Researchers at Hokkaido University in Japan, in a collaboration with American scientists, may have unlocked the mechanism that drives widespread inflammation in inflammatory diseases.

  May 18, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano M.S.
• 

  The Highest Paying Life Science Jobs in 2022

  BioSpace surveyed thousands of industry professionals to get the most current, accurate salary statistics. Read on to find out the top-paying jobs in each sector.

  May 18, 2022

   · 

  2 min read

   · 

  Rosemary Scott
• 

  Drug Development

  Applied Molecular Transport Shifts Gear, Cuts Workforce by 40%

  Applied Molecular Transport (AMT) provided a strategy update on Wednesday. Part of the update includes reducing its workforce by about 40% and funneling resources into its lead program.

  May 18, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Drug Development

  Global Roundup: Prota’s Immunotherapy Shows Success Against Peanut Allergy

  In a Phase IIb study, data showed that Prota Therapeutics’ oral immunotherapy led to 51% of children reaching clinical remission of their peanut allergy compared to placebo. See inside for this and more!

  May 18, 2022

   · 

  8 min read

   · 

  Alex Keown